Clinical trial
Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial
NCT00219700 · PLx Pharma, Industry · Completed
Key facts
| NCT number | NCT00219700 |
|---|---|
| Title | Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial |
| Official title | Phase II, Randomized, Blinded Study of Ibuprofen-PC and Ibuprofen in Patients With Osteoarthritis to Investigate Efficacy and Gastrointestinal Toxicity |
| Lead sponsor | PLx Pharma, Industry |
| Collaborators | National Institutes of Health (NIH) NIH Texas Higher Education Coordinating Board |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug |
| Interventions | Ibuprofen-PC |
| Enrollment | 125 |
| Start date | Jan 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 26, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: